NYSE
PRGO

Perrigo Company PLC

Drug Manufacturers-Specialty & Generic
Healthcare

Prices are adjusted according to historical splits.

Perrigo Company PLC Stock Price

Vitals

Today's Low:
$33.8499
Today's High:
$34.18
Open Price:
$34.13
52W Low:
$30.062
52W High:
$40.1469
Prev. Close:
$34.14
Volume:
1021122

Company Statistics

Market Cap.:
$4.62 billion
Book Value:
35.809
Revenue TTM:
$4.63 billion
Operating Margin TTM:
5.58%
Gross Profit TTM:
$1.46 billion
Profit Margin:
-1.46%
Return on Assets TTM:
1.48%
Return on Equity TTM:
-1.17%

Company Profile

Perrigo Company PLC had its IPO on 1991-12-16 under the ticker symbol PRGO.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Perrigo Company PLC has a staff strength of 8,900 employees.

Stock update

Shares of Perrigo Company PLC opened at $34.13 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $33.85 - $34.18, and closed at $33.91.

This is a -0.67% slip from the previous day's closing price.

A total volume of 1,021,122 shares were traded at the close of the day’s session.

In the last one week, shares of Perrigo Company PLC have slipped by -6.2%.

Perrigo Company PLC's Key Ratios

Perrigo Company PLC has a market cap of $4.62 billion, indicating a price to book ratio of 0.9244 and a price to sales ratio of 0.9679.

In the last 12-months Perrigo Company PLC’s revenue was $4.63 billion with a gross profit of $1.46 billion and an EBITDA of $626.50 million. The EBITDA ratio measures Perrigo Company PLC's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Perrigo Company PLC’s operating margin was 5.58% while its return on assets stood at 1.48% with a return of equity of -1.17%.

In Q2, Perrigo Company PLC’s quarterly earnings growth was a negative -63.6% while revenue growth was a positive 6.4%.

Perrigo Company PLC’s PE and PEG Ratio

Forward PE
10.8932
Trailing PE
0
PEG
2.45

Its diluted EPS in the last 12-months stands at $-0.42 per share while it has a forward price to earnings multiple of 10.8932 and a PEG multiple of 2.45. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Perrigo Company PLC’s profitability.

Perrigo Company PLC stock is trading at a EV to sales ratio of 1.7943 and a EV to EBITDA ratio of 22.8499. Its price to sales ratio in the trailing 12-months stood at 0.9679.

Perrigo Company PLC stock pays annual dividends of $1.066 per share, indicating a yield of 3.19% and a payout ratio of 45.15%.

Balance sheet and cash flow metrics

Total Assets
$10.96 billion
Total Liabilities
$1.06 billion
Operating Cash Flow
$-4400000.00
Capital Expenditure
$20 million
Dividend Payout Ratio
45.15%

Perrigo Company PLC ended 2024 with $10.96 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $10.96 billion while shareholder equity stood at $4.85 billion.

Perrigo Company PLC ended 2024 with $344.60 million in deferred long-term liabilities, $1.06 billion in other current liabilities, 6890900000.00 in common stock, $-2062200000.00 in retained earnings and $3.66 billion in goodwill. Its cash balance stood at $555.20 million and cash and short-term investments were $555.20 million. The company’s total short-term debt was $38,400,000 while long-term debt stood at $4.06 billion.

Perrigo Company PLC’s total current assets stands at $2.77 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $754.10 million compared to accounts payable of $470.50 million and inventory worth $1.17 billion.

In 2024, Perrigo Company PLC's operating cash flow was $-4400000.00 while its capital expenditure stood at $20 million.

Comparatively, Perrigo Company PLC paid $0.45 in dividends in 2024.

Other key metrics

Current Trading Price
$33.91
52-Week High
$40.1469
52-Week Low
$30.062
Analyst Target Price
$49

Perrigo Company PLC stock is currently trading at $33.91 per share. It touched a 52-week high of $40.1469 and a 52-week low of $40.1469. Analysts tracking the stock have a 12-month average target price of $49.

Its 50-day moving average was $35.62 and 200-day moving average was $34.59 The short ratio stood at 4.36 indicating a short percent outstanding of 0%.

Around 94.8% of the company’s stock are held by insiders while 9872.1% are held by institutions.

Frequently Asked Questions About Perrigo Company PLC

The stock symbol (also called stock or share ticker) of Perrigo Company PLC is PRGO

The IPO of Perrigo Company PLC took place on 1991-12-16

Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)

Last Price
Chg
Chg%
$27.7
0
0%
$2.2
-0.05
-2.22%
$12.53
0.14
+1.13%
$532
-25.8
-4.63%
$35
-0.71
-1.99%
$15.2
0.7
+4.83%
$967.45
-1.7
-0.18%
ABB Ltd (ABLZF)
$36.34
-1.24
-3.3%
$2073.45
-197.7
-8.7%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in Ireland, the United States, France, Belgium, China, the United Kingdom, Germany, Switzerland, Austria, Italy, Australia, Greece, and Spain. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The Consumer Self-Care Americas segment develops, manufacture, and markets self-care products including upper respiratory, pain and sleep-aids, digestive health, nutrition, healthy lifestyle, skincare, women’s health, and other products, as well as vitamins, minerals and supplements, and oral self-care in the United States and Canada. This segment offers its products under Burt’s Bees, Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, and Steripod brands. Consumer Self-Care International segment comprises consumer self-care product categories outside the U.S. and Canada, including branded products in Europe and Australia, and store brand products in the United Kingdom and parts of Europe and Asia, which develops, manufactures, markets, and distributes consumer self-care brands through a network of drug and grocery store retailers, e-commerce stores, and para-pharmacies in more than 29 countries, primarily in Europe. In addition, the company offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Address

The Sharp Building, Dublin, Ireland, 2